Multimorbidity phenotypes in patients presenting to the emergency department with possible acute coronary syndrome
Katherine M Breen1, Lorna Finnegan2, Karen M Vuckovic3
1Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Road, Atlanta, GA 30322, United States.
Insights
Identifying multimorbidity phenotypes in acute coronary syndrome (ACS) patients is crucial. Four distinct groups emerged, with cardiovascular and cardio-oncology phenotypes showing higher ACS likelihood, aiding risk stratification.
Area of Science:
- Cardiology
- Clinical Medicine
- Health Services Research
Background:
- Multimorbidity, defined as having more than two health conditions, complicates acute coronary syndrome (ACS) care.
- Current ACS clinical guidelines are single-disease focused and do not adequately address multimorbidity.
- This gap challenges healthcare systems and can lead to adverse patient outcomes.
Purpose of the Study:
- To identify distinct multimorbidity phenotypes (combinations of conditions) in patients with suspected ACS.
- To determine if these phenotypes differ by diagnosis, sex, age, functional status, family history, and discharge diagnosis.
- To improve risk stratification and patient triage for ACS.
Main Methods:
- Secondary analysis of a large, multi-site clinical study involving patients with suspected ACS.
- Utilized latent class analysis to identify patient subgroups based on multimorbidity patterns.
- Comorbidities were assessed using the Charlson Comorbidity Index and the ACS Patient Information Questionnaire.
Main Results:
- Identified four distinct multimorbidity phenotypes among 935 patients.
- Phenotypes included: high multimorbidity (e.g., diabetes, hypertension), low multimorbidity (obesity only), cardiovascular, and cardio-oncology.
- Patients with cardiovascular (OR 2.82) and cardio-oncology (OR 1.76) phenotypes were significantly more likely to be diagnosed with ACS.
Conclusions:
- Distinct multimorbidity phenotypes exist within the ACS patient population.
- These phenotypes have varying associations with ACS diagnosis.
- Understanding these phenotypes can enhance risk stratification and emergency department triage for high-risk patients.
Background:
Multimorbidity (> 2 conditions) increases the risk of adverse outcomes and challenges health care systems for patients with acute coronary syndrome (ACS). These complications may be partially attributed to ACS clinical care which is driven by single-disease-based practice guidelines; current guidelines do not consider multimorbidity.
Objectives:
To identify multimorbidity phenotypes (combinations of conditions) with suspected ACS. We hypothesized that: 1) subgroups of patients with similar multimorbidity phenotypes could be identified, 2) classes would differ according to diagnosis, and 3) class membership would differ by sex, age, functional status, family history, and discharge diagnosis.
Methods:
This was a secondary analysis of data from a large multi-site clinical study of patients with suspected ACS. Conditions were determined by items on the Charlson Comorbidity Index and the ACS Patient Information Questionnaire. Latent class analysis was used to identify phenotypes.
Results:
The sample (n = 935) was predominantly male (68%) and middle-aged (mean= 59 years). Four multimorbidity phenotypes were identified: 1) high multimorbidity (Class 1) included hyperlipidemia, hypertension (HTN), obesity, diabetes, and respiratory disorders (COPD or asthma); 2) low multimorbidity (Class 2) included only obesity; 3) cardiovascular multimorbidity (Class 3) included HTN, hyperlipidemia, and coronary heart disease; and 4) cardio-oncology multimorbidity (Class 4) included HTN, hyperlipidemia, and cancer. Patients ruled-in for ACS primarily clustered in Classes 3 and 4 (OR 2.82, 95% CI 1.95-4.05, p = 0.001 and OR 1.76, 95% CI 1.13-2.74, p = 0.01).
Conclusion:
Identifying and understanding multimorbidity phenotypes may assist with risk-stratification and better triage of high-risk patients in the emergency department.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Introduction Cardiac Emergencies
